tiprankstipranks
Trending News
More News >

ChitogenX Shows Financial Improvement in Q3 2025

Story Highlights
  • ChitogenX Inc. reduced its net loss to $0.6 million in Q3 2025, improving by 23% from last year.
  • The company achieved a 71% reduction in EBITDA loss year-to-date by minimizing operating expenses.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
ChitogenX Shows Financial Improvement in Q3 2025

ChitogenX (TSE:CHGX) has released an update.

Confident Investing Starts Here:

ChitogenX Inc. reported a reduced net loss of $0.6 million for the third quarter of 2025, marking a 23% improvement from the previous year. The company also achieved a significant 71% reduction in EBITDA loss year-to-date, reflecting their efforts to minimize operating expenses and focus on securing funding through partnerships.

For further insights into TSE:CHGX stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1